Martin F. Jackson - Jun 16, 2021 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)

Role: Executive Vice President
Signature: /s/ Michael E. Tarvin, as attorney-in-fact
Stock symbol: SEM
Transactions as of: Jun 16, 2021
Transactions value $: -$4,261,000
Form type: 4
Date filed: 6/17/2021, 07:14 PM
Previous filing: Jun 1, 2021
Next filing: Aug 3, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SEM	Common Stock	Sale	-$4.26M	-100K	-8.81%	$42.61	1.04M	Jun 16, 2021	Direct	F1
holding	SEM	Common Stock						2.63K	Jun 16, 2021	By son	F2
holding	SEM	Common Stock						2.63K	Jun 16, 2021	By son	F2
holding	SEM	Common Stock						2.63K	Jun 16, 2021	By daughter	F2
holding	SEM	Common Stock						2.63K	Jun 16, 2021	By son	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.50 to $43.14, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.50 to $43.14, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.